Pricing Log in Create free account

Cardiff Oncology, Inc. (CRDF) vs Tenax Therapeutics, Inc. (TENX)

Cardiff Oncology, Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. Cardiff Oncology, Inc. and Tenax Therapeutics, Inc. are of similar size ($61.0M and $58.8M). Cardiff Oncology, Inc. grew revenue faster over the last twelve months: −6.79% against −70.8%. Tenax Therapeutics, Inc. has the higher net margin (0.00% vs −7,889.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Tenax Therapeutics, Inc. leads on 9 and Cardiff Oncology, Inc. on 7.

Valuation

Metric CRDF TENX Biotechnology median
P/E n/m n/m 10.26
P/S 102.33 242.52 9.18
P/B 1.96 0.73 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.50 0.65
EV/Sales 37.15 (100.35) 8.98
Earnings yield (78.95%) (90.24%) (34.89%)
Free cash flow yield (78.76%) (55.21%) (24.52%)

Profitability

Metric CRDF TENX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (8,320.08%) 0.00% 0.00%
Net margin (7,888.98%) 0.00% 0.00%
Free cash flow margin (8,059.45%) 0.00% 0.00%
Return on equity (94.14%) (59.80%) (50.12%)
Return on assets (70.89%) (57.02%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRDF TENX Biotechnology median
Revenue growth (TTM) (6.79%) (70.77%) 6.26%
EPS growth (last fiscal year) 27.37% (16.52%) 29.88%
Revenue growth, 5-year CAGR 10.13% 0.79% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRDF TENX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.30 15.07 4.89
Net debt to EBITDA 1.18 1.73 1.01

Dividend

Metric CRDF TENX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRDF TENX Biotechnology median
Market cap 58.76m 61.00m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack